DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

Blood Cancer Journal, Published online: 28 April 2020; doi:10.1038/s41408-020-0292-7DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

Source: Blood Cancer Journal - April 27, 2020 Category: Hematology Authors: Simone C. Oostindie Hilma J. van der Horst Laurens P. Kil Kristin Strumane Marije B. Overdijk Edward N. van den Brink Jeroen H. N. van den Brakel Hendrik J. Rademaker Berris van Kessel Juliette van den Noort Martine E. D. Chamuleau Tuna Mutis Margaret A. Source Type: research